Literature DB >> 21731081

Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade.

Charles Aidemise Oyinbo1.   

Abstract

The pathophysiology of acute spinal cord injury (SCI) involves primary and secondary mechanisms of injury. Though both mechanisms are involved in the neurological dysfunction in SCI most research however has focused on understanding the pathophysiology of the secondary damage and reducing the amount of delayed cell loss following SCI. Research has revealed extensive therapeutic windows in secondary injury mechanisms that could be manipulated by appropriate exogenous interventions. In contrast, primary injury to the cord happens unexpectedly, and it is associated with inevitable delays; ranging from several hours to days before care intervention is administered. Therefore, apart from achieving patient's stabilization, the therapeutic window in the primary phase of injury is essentially obliterated, and consequently inaccessible for specialized. Coupled to this, the exacerbating effect of secondary injury mechanisms has generally commenced before the specialist intervention. Hence, knowledge of secondary injury mechanisms and their intricacies are invaluable requisite for any tailored therapeutic strategy in the persistent search for a cure of SCI. There are about 25 well-established secondary injury mechanisms in SCI, and are found in bits or clusters in literature. A vast number of these articles are not open access. Besides, articles with a comprehensive catalog of these mechanisms are not readily available. This article has cataloged over twenty five identified secondary mechanisms of injury in the spinal cord in an open access portal, and is particularly versatile for starters in spinal cord injury research.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21731081

Source DB:  PubMed          Journal:  Acta Neurobiol Exp (Wars)        ISSN: 0065-1400            Impact factor:   1.579


  229 in total

1.  Acute administration of AMPA/Kainate blocker combined with delayed transplantation of neural precursors improves lower urinary tract function in spinal injured rats.

Authors:  Takahiko Mitsui; Birgit Neuhuber; Itzhak Fischer
Journal:  Brain Res       Date:  2011-08-22       Impact factor: 3.252

2.  Photothrombosis-induced Focal Ischemia as a Model of Spinal Cord Injury in Mice.

Authors:  Hailong Li; Gourav Roy Choudhury; Nannan Zhang; Shinghua Ding
Journal:  J Vis Exp       Date:  2015-07-16       Impact factor: 1.355

3.  Noninvasive Quantification of Axonal Loss in the Presence of Tissue Swelling in Traumatic Spinal Cord Injury Mice.

Authors:  Tsen-Hsuan Lin; Peng Sun; Mitchell Hallman; Fay C Hwang; Michael Wallendorf; Wilson Z Ray; William M Spees; Sheng-Kwei Song
Journal:  J Neurotrauma       Date:  2019-01-11       Impact factor: 5.269

4.  Evaluating accessibility of intravenously administered nanoparticles at the lesion site in rat and pig contusion models of spinal cord injury.

Authors:  Yue Gao; Sivakumar Vijayaraghavalu; Melinda Stees; Brian K Kwon; Vinod Labhasetwar
Journal:  J Control Release       Date:  2019-03-28       Impact factor: 9.776

Review 5.  Biomarkers in Spinal Cord Injury: from Prognosis to Treatment.

Authors:  Leonardo Fonseca Rodrigues; Vivaldo Moura-Neto; Tania Cristina Leite de Sampaio E Spohr
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

Review 6.  Mesenchymal stem cells in the treatment of spinal cord injuries: A review.

Authors:  Venkata Ramesh Dasari; Krishna Kumar Veeravalli; Dzung H Dinh
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

7.  A Dual Role for Hyperbaric Oxygen in Stroke Neuroprotection: Preconditioning of the Brain and Stem Cells.

Authors:  Grant M Liska; Trenton Lippert; Eleonora Russo; Norton Nieves; Cesar V Borlongan
Journal:  Cond Med       Date:  2018-06

8.  Evaluation of poly(3,4-ethylenedioxythiophene)/carbon nanotube neural electrode coatings for stimulation in the dorsal root ganglion.

Authors:  Christi L Kolarcik; Kasey Catt; Erika Rost; Ingrid N Albrecht; Dennis Bourbeau; Zhanhong Du; Takashi D Y Kozai; Xiliang Luo; Douglas J Weber; X Tracy Cui
Journal:  J Neural Eng       Date:  2014-12-08       Impact factor: 5.379

Review 9.  Sphingolipids in spinal cord injury.

Authors:  Zachary B Jones; Yi Ren
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-08-05

10.  Pharmacological Stimulation of Mitochondrial Biogenesis Using the Food and Drug Administration-Approved β2-Adrenoreceptor Agonist Formoterol for the Treatment of Spinal Cord Injury.

Authors:  Natalie E Scholpa; Hannah Williams; Wenxue Wang; Daniel Corum; Aarti Narang; Stephen Tomlinson; Patrick G Sullivan; Alexander G Rabchevsky; Rick G Schnellmann
Journal:  J Neurotrauma       Date:  2018-11-16       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.